Latest Property Portfolio News

Proteomics International has achieved a major milestone with the first worldwide patent granted in Japan for its PromarkerEndo blood test, designed to diagnose endometriosis early and accurately.

Anagenics Limited’s licensed brand Bouf Haircare is outperforming expectations with strong early sales and promising royalty returns, signaling robust growth potential for the company’s intellectual property portfolio.

Oceania Healthcare has modernized its property portfolio and updated its dividend policy to align with a new strategic direction under CEO Suzanne Dvorak, aiming to meet New Zealand's growing aged care demand.

BWP Trust has announced a significant $45 million net gain from property revaluations for the second half of FY2025, driven by rising rents and a slight compression in capitalisation rates.

Garda Property Group has reported a modest increase in the valuation of its industrial property portfolio, lifting the total to over $521 million ahead of its FY25 annual report.

Dexus reports a slight 0.4% increase in portfolio valuations driven by rental growth, alongside an 18-cent estimated distribution. Meanwhile, legal proceedings involving its APAC stake face delays, clouding future outcomes.

Charter Hall has announced a 6% increase in its half-year distribution to 24.38 cents per security for the period ending June 30, 2025, signaling steady growth in its property investment returns.

Stockland has announced an estimated distribution of 17.2 cents per security for the second half of 2025, maintaining its full-year guidance. The company also offers a 1% discount through its Distribution Reinvestment Plan, encouraging shareholder participation.

GPT Group has announced an estimated distribution of 12.0 cents per stapled security for the first half of 2025, setting the stage ahead of its interim results release in August.

Centuria Capital Group has announced a fully franked ordinary dividend of AUD 0.052 per security for the six months ending June 30, 2025, payable on August 19, 2025. This steady payout underscores the group's ongoing commitment to delivering shareholder value amid a stable property investment environment.

Region Group reports a $54.4 million uplift in its investment property portfolio valuation as of June 30, 2025, driven by acquisitions and like-for-like gains, while maintaining stable gearing and net tangible assets growth.

Recce Pharmaceuticals has locked in a non-dilutive A$30 million debt facility with Avenue Capital Group, extending its cash runway to support pivotal Phase 3 trials and commercialisation of its synthetic anti-infective R327G.